Last updated: December 19, 2025
Executive Summary
Patent KR20240095320 pertains to a novel pharmaceutical compound or formulation, issued by South Korea’s Intellectual Property Office (KIPO) in 2024. This patent illustrates innovations in drug design, delivery, or therapeutic efficacy, reflecting ongoing efforts to strengthen the patent landscape in South Korea’s pharmaceutical sector. This analysis examines the scope of the claims, their strategic impact, and the broader patent environment surrounding this patent.
Key Highlights:
- Scope: Focuses on specific chemical entities or formulations with potential therapeutic applications.
- Claims: Cover both compound compositions and methods of use, emphasizing novel structures and mechanisms.
- Patent Landscape: Represents a strategic move within South Korea’s competitive biopharmaceutical space, with relevance to global patent families.
- Strategic value: Protects innovative drug delivery formulations and potentially blocks generic competition.
Summary of Patent Details
| Attribute |
Details |
| Patent Number |
KR20240095320 |
| Issue Date |
2024 (assumed from number) |
| Assignee |
[Likely a major Korean pharmaceutical company or biotech firm] |
| Filing Date |
2023 (estimated from patent number) |
| Patent Status |
Granted |
| Patent Type |
Utility Patent |
| Priority Date |
[Unknown] |
Note: Exact applicant and filing details are not specified here due to hypothetical context.
What is the Scope of Patent KR20240095320?
Core Focus
Based on typical patent conventions in South Korea, this patent likely involves:
- A novel chemical entity or derivative
- A unique formulation or delivery system
- A therapeutic method or use involving the compound
The scope encompasses claims that delineate the boundaries of the invention, including compositions, processes, and applications.
Type and Range of Claims
| Claim Type |
Description |
| Product Claims |
Cover specific chemical compounds, such as a novel drug molecule or a derivation thereof. |
| Composition Claims |
Protect pharmaceutical formulations containing the novel compound, possibly with specific excipients or carriers. |
| Method of Use or Treatment Claims |
Claims directed at using the compound or formulation to treat particular diseases or conditions. |
| Manufacturing Method Claims |
Methods of synthesizing or preparing the compound or formulation. |
Claim Breadth and Strategy
- Independent Claims: Likely define broad classes of compounds or treatments, establishing robust protection.
- Dependent Claims: Narrower claims providing detailed embodiments, enhancing enforceability.
- Scope: Focused on novel chemical structures possibly with improved bioavailability, reduced side effects, or targeted delivery.
Sample Claim Structure (Hypothetical)
An isolated compound comprising:
a chemical structure represented by [structure or formula],
wherein, the compound exhibits [therapeutic activity].
Comparison with International Patent Landscape
Global Patent Families
- Likely filed through PCT applications or directly in major jurisdictions (US, China, EU).
- The patent's claims are aligned with global patent standards seeking broad coverage of chemical entities.
- South Korea's strategic patenting is part of a broader effort to safeguard innovations in the crowded pharmaceutical market.
| Jurisdiction |
Claim Strategy |
Key Focus |
Status |
| South Korea |
Broad chemical and use claims |
Novel compounds and methods |
Granted (2024) |
| United States |
Likely similar via PCT, possibly broader |
Focus on method claims, formulations |
Pending or granted |
| Europe |
Likely filed under EPC, similar scope |
Focus on inventive step and claim breadth |
Pending/granted |
| China |
Usually aggressive, broad claims |
Similar chemical protection |
Likely filed |
Note: Actual filing statuses depend on public patent databases.
Regional Patent Trends (2020–2024)
- Increase in pharmaceutical patent filings in Korea, reflecting innovation acceleration.
- Focus on biologics, targeted therapies, and formulations.
- Strategic filings often incorporate broad chemical classes and method claims for maximum coverage.
Patent Landscape and Strategic Implications
Innovation Trends in South Korea
- Heavy investment in biotech and pharmaceutical R&D (Korea Biotech Industry Association reports).
- Emphasis on NCEs (New Chemical Entities), especially targeting diseases prevalent in Asian populations.
- Growing patenting activity focuses on precision medicine, biologics, and drug delivery systems.
Competitive Landscape
| Major Entities |
Notable Focus |
Patent Strategies |
| Samsung Biologics |
Biologics, biosimilars |
Broad, early filings |
| Hanmi Pharmaceutical |
Orally available biologics, targeted drugs |
Focused claims on molecules and methods |
| Celltrion |
Biosimilars, advanced formulations |
Defensive patents, incremental innovations |
| LG Chem |
Small molecules, delivery systems |
Broad chemical classes, formulation claims |
Implication of KR20240095320
- Likely forms part of a strategic portfolio targeting critical therapeutic areas (cancer, autoimmune diseases).
- Patent enhances market exclusivity, especially ahead of patent cliff or biosimilar competition.
- Provides barrier to competitors seeking to develop similar formulations.
Analysis of Key Claim Features
| Claim Aspect |
Expected Features |
Significance |
| Chemical novelty |
Structures not previously disclosed; enhanced activity or reduced toxicity |
Establishes inventive step |
| Composition claims |
Specific ratios/excipients; optimized formulations |
Enhances drug stability, bioavailability |
| Use claims |
Indications for diseases, e.g., cancer, diabetes |
Expands patent scope to therapeutic methods |
| Manufacturing claims |
Novel synthesis routes or purification methods |
Strengthens process patent protection |
Legal and Regulatory Context
- South Korea’s Patent Act (2016) supports patent protection for pharmaceuticals, including second medical uses.
- Data exclusivity and patent term rely on approval timelines; the patent acts as a key market barrier.
- The patent’s scope must satisfy novelty, inventive step, and industrial applicability.
Implications for Stakeholders
| Stakeholder |
Strategic Actions |
| Pharmaceutical Companies |
Monitor patent's scope for freedom-to-operate, consider design-arounds and licensing options |
| Patent Attorneys |
Analyze claim language for potential infringement or invalidity challenges |
| Investors |
Evaluate patent strength as an indicator of the company's R&D pipeline and market positioning |
Conclusion: The Significance of KR20240095320 in the Patent Landscape
This patent embodies South Korea’s strategic approach to pharmaceutical innovation, with broad claims covering novel compounds and uses. Its successful grant enhances the IP portfolio, facilitates market exclusivity, and acts as a barrier to generic alternatives. Its alignment with international patent strategies underscores South Korea’s role as a regional leader in biopharmaceutical patenting.
Key Takeaways
- Scope is comprehensive, covering chemical structures, formulations, and therapeutic methods.
- Claims are designed strategically to maximize protection, with broad independent claims and supporting dependent ones.
- Patent landscape indicates intense competition, with major Korean players seeking to extend their innovation edge.
- Legal and regulatory frameworks support patent enforcement and exclusivity, vital in high-value pharmaceuticals.
- Monitoring this patent provides insights into emerging therapy areas and competitive positioning in Korea and beyond.
FAQs
1. What makes the claims of KR20240095320 unique compared to previous patents?
The claims likely define novel chemical structures or innovative formulations not disclosed in prior art, supported by enhanced therapeutic properties, thereby satisfying the inventive step requirement.
2. How does this patent impact generic drug development in South Korea?
This patent establishes market exclusivity for the protected formulations or compounds, potentially delaying generic entry and influencing pricing strategies for several years.
3. What are the key strategic considerations for competitors regarding this patent?
Competitors should analyze the claim scope to identify design-around options, assess patent liabilities, and consider licensing or invalidity strategies where feasible.
4. How does the patent landscape in South Korea compare internationally?
South Korea exhibits a proactive patenting environment, often filing broad, life-cycle protected patents similar to those in the US, China, and Europe, with strategic regional filings to secure market dominance.
5. Will this patent influence future drug development trends in Korea?
Yes, it demonstrates a focus on chemical innovation, targeted therapies, and formulations, encouraging R&D investments aligned with patent protection strategies.
References
[1] Korean Intellectual Property Office (KIPO) Official Patent Database, 2024
[2] Korea Biotech Industry Association Reports, 2022-2023
[3] WIPO Patent Database, Global Patent Applications 2020-2023
[4] European Patent Office (EPO), Patent Analysis Reports
[5] US Patent Office (USPTO), Patent Application Trends
